Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Jaguar Health (JAGX) Leases (2019 - 2025)

Jaguar Health (JAGX) has disclosed Leases for 6 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Leases changed 0.47% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 0.47% change, with the full-year FY2024 number at $936000.0, down 20.41% from a year prior.
  • Leases was $1.1 million for Q3 2025 at Jaguar Health, down from $1.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $1.3 million in Q1 2024 to a low of $824000.0 in Q3 2023.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2021 define the central range for Leases.
  • Peak YoY movement for Leases: fell 25.36% in 2023, then increased 28.28% in 2024.
  • Jaguar Health's Leases stood at $1.1 million in 2021, then grew by 5.17% to $1.1 million in 2022, then rose by 3.16% to $1.2 million in 2023, then decreased by 20.41% to $936000.0 in 2024, then increased by 13.46% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Leases are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.2 million (Q1 2025).